You wouldn’t use a general business CRM to manage clinical trials. So why are so many biotech companies still trying to fit generic procurement tools into specialized R&D workflows?
While procurement systems designed for other industries might check the boxes for basic sourcing or finance workflows, they often fall short in research-driven environments. Labs, after all, are sourcing way more than standard office supplies. They’re procuring antibodies, reagents, specialized chemicals, and scientific equipment from niche suppliers with unpredictable lead times and backorder risks.
Here’s why biotech teams often struggle with generic procurement tools, and why specialized biotech procurement tools are essential.
If your team is constantly struggling with your generic procurement tool, it’s time to reconsider your platform.
Industry experts agree: as biotech companies evolve, procurement needs to move beyond cost-cutting to become a driver of value and speed. In a recent Business of Biotech episode titled “Proactive Procurement Strategies For Biotech With Tom Wells", the discussion outlines the importance of aligning procurement with innovation and operational agility, something generic tools struggle to support.
Biotech workflows demand specialized solutions. The stakes are higher, the purchasing landscape more complex, and the pace of research too important to be slowed down by systems that weren’t designed for you.
ZAGENO is built for this.